Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride

Movement Disorders

Volumn 25, Issue 16, 2010, Pages 2777-2784

  Vučcković, Marta G ^a,b   Li, Quanzheng ^c   Fisher, Beth ^a   Nacca, Angelo ^b   Leahy, Richard M ^c   Walsh, John P ^d   Mukherjee, Jogesh ^e   Williams, Celia ^b   Jakowec, Michael W ^a,b   Petzinger, Giselle M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NONE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basal ganglia; Neuroplasticity; Positron emission tomography; Treadmill exercise

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FALLYPRIDE FLUORODEOXYGLUCOSE F 18; FLUORODEOXYGLUCOSE F 18; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BINDING AFFINITY; BRAIN NERVE CELL; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTOSOME; TREADMILL EXERCISE; WESTERN BLOTTING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANALYSIS OF VARIANCE; ANIMALS; BENZAMIDES; BLOTTING, WESTERN; CORPUS STRIATUM; MALE; MICE; MICE, INBRED C57BL; NEURONS; PARKINSON DISEASE, SECONDARY; PHYSICAL CONDITIONING, ANIMAL; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RECEPTORS, DOPAMINE D2;

EID: 78650226199     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23407     Document Type: Article

References (36)

1. Bergen JL, Toole T, Elliott RGr, Wallace B, Robinson K, Maitland CG. Aerobic exercise intervention improves aerobic capacity and movement initiation in Parkinson's disease patients. NeuroRehabilitation 2002; 17: 16-168.
2. Comella CL, Stebbins GT, Brown-Toms N, Goetz CG. Physical therapy and Parkinson's disease: a controlled clinical trial. Neurology 1994; 44(3 Part 1): 376-378.
3. Schenkman M, Hall D, Kumar R, Kohrt WM. Endurance exercise training to improve economy of movement of people with Parkinson disease: three case reports. Phys Ther 2008; 88: 63-76.
4. Pothakos K, Kurz MJ, Lau YS. Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration. BMC Neurosci 2009; 10: 1-14.
5. Fisher BE, Petzinger GM, Nixon K, et al. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 2004; 77: 378-390.
6. Petzinger GM, Walsh JP, Akopian G, et al. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci 2007; 27: 5291-5300.
7. Wang GJ, Volkow ND, Fowler JS, et al. PET studies of the effects of aerobic exercise on human striatal dopamine release. J Nucl Med 2000; 41: 1352-1356.
8. Ginovart N, Farde L, Halldin C, Swahn CG. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain. Synapse 1997; 25: 321-325.
9. Mukherjee J, Christian BT, Narayanan TK, Shi B, Mantil J. Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride. Neuropsychopharmacology 2001; 25: 476-488.
10. Honer M, Bruhlmeier M, Missimer J, Schubiger AP, Ametamey SM. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET. J Nucl Med 2004; 45: 464-470.
11. Falardeau P, Bedard PJ, Di Paolo T. Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys. Neurosci Lett 1988; 86: 225-229.
12. Mukherjee J, Yang ZY, Brown T, et al. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. Nucl Med Biol 1999; 26: 519-527.
13. Christian BT, Narayanan TK, Shi B, Mukherjee J. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates. Synapse 2000; 38: 71-79.
14. Qi J, Leahy RM, Cherry SR, Chatziioannou A, Farquhar TH. High-resuulution 3D Bayesian image reconstruction using microPET small-animal scanner. Phys Med Biol 1998; 43: 1001-1013.
15. Ichise M, Toyama H, Innis RB, Carson RE. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab 2002; 22: 1271-1281.
16. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996; 16: 834-840.
17. Studholme C, Hill DL, Hawkes DJ. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys 1997; 24: 25-35.
18. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984; 15: 217-227.
19. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4(3 Part 1): 153-158.
20. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. Second ed. New York: Academic Press; 2001.
21. Johnson MW, Chotiner JK, Watson JB. Isolation and characterization of synaptoneurosomes from single rat hippocampal slices. J Neurosci Methods 1997; 77: 151-156.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-685.
23. Thomas JR, Salazar W, Landers DM. What is missing in p < .05? Effect size. Res Q Exerc Sport 1991; 62: 344-348.
24. Cropley VL, Innis RB, Nathan PJ, et al. Small effect of dopamine release and no effect of dopamine depletion on [(18)F]fallypride binding in healthy humans. Synapse 2008; 62: 399-408.
25. Hurley MJ, Jenner P. What has been learnt from study of dopamine receptors in Parkinson's disease? Pharmacol Ther 2006; 111: 715-728.
26. Smith Y, Villalba R. Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains. Mov Disord 2008; 23( Suppl 3): S534-S547.
27. Cepeda C, Buchwald NA, Levine MS. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci USA 1993; 90: 9576-9580.
28. Levine MS, Altemus KL, Cepeda C, et al. Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice. J Neurosci 1996; 16: 5870-5882.
29. Umemiya M, Raymond LA. Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons. J Neurophysiol 1997; 78: 1248-1255.
30. Day M, Wang Z, Ding J, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006; 9: 251-259.
31. VanLeeuwen JE, Petzinger GM, Walsh JP, Akopian GK, Vuckovic M, Jakowec MW. Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci Res 2010; 88: 650-668.
32. Hernandez-Echeagaray E, Starling AJ, Cepeda C, Levine MS. Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary? Eur J Neurosci 2004; 19: 2455-2463.
33. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007; 30: 228-235.
34. Calabresi P, Mercuri NB, Sancesario G, Bernardi G. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain 1993; 116(Part 2): 433-452.
35. Ballion B, Frenois F, Zold CL, Chetrit J, Murer MG, Gonon F. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. Neurobiol Dis 2009; 35: 376-384.
36. Calabresi P, Pisani A, Centonze D, Bernardi G. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neurosci Biobehav Rev 1997; 21: 519-523.